Literature DB >> 9218502

The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.

H M Siragy1, R M Carey.   

Abstract

The angiotensin AT2 receptor modulates renal production of cyclic guanosine 3',5'-monophosphate (cGMP; J. Clin. Invest. 1996. 97:1978-1982). In the present study, we hypothesized that angiotensin II (Ang II) acts at the AT2 receptor to stimulate renal production of nitric oxide leading to the previously observed increase in cGMP. Using a microdialysis technique, we monitored changes in renal interstitial fluid (RIF) cGMP in response to intravenous infusion of the AT2 receptor antagonist PD 123319 (PD), the AT1 receptor antagonist Losartan, the nitric oxide synthase (NOS) inhibitor nitro--arginine-methyl-ester (-NAME), the specific neural NOS inhibitor 7-nitroindazole (7-NI), or Ang II individually or combined in conscious rats during low or normal sodium balance. Sodium depletion significantly increased RIF cGMP. During sodium depletion, both PD and -NAME caused a similar decrease in RIF cGMP. Combined administration of PD and -NAME decreased RIF cGMP to levels observed with PD or -NAME alone or during normal sodium intake. During normal sodium intake, Ang II caused a twofold increase in RIF cGMP. Neither PD nor -NAME, individually or combined, changed RIF cGMP. Combined administration of Ang II and either PD or -NAME produced a significant decrease in RIF cGMP compared with that induced by Ang II alone. Combined administration of Ang II, PD, and -NAME blocked the increase in RIF cGMP produced by Ang II alone. During sodium depletion, 7-NI decreased RIF cGMP, but the reduction of cGMP in response to PD alone or PD combined with 7-NI was greater than with 7-NI alone. During normal sodium intake, 7-NI blocked the Ang II-induced increase in RIF cGMP. PD alone or combined with 7-NI produced a greater inhibition of cGMP than did 7-NI alone. During sodium depletion, 7-NI (partially) and -NAME (completely) inhibited RIF cGMP responses to -arginine. These data demonstrate that activation of the renin- angiotensin system during sodium depletion increases renal nitric oxide production through stimulation by Ang II at the angiotensin AT2 receptor. This response is partially mediated by neural NOS, but other NOS isoforms also contribute to nitric oxide production by this pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218502      PMCID: PMC508188          DOI: 10.1172/JCI119531

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics.

Authors:  L G Navar; L Rosivall
Journal:  Kidney Int       Date:  1984-06       Impact factor: 10.612

Review 2.  Importance of nitric oxide in the control of renal hemodynamics.

Authors:  C Baylis; C Qiu
Journal:  Kidney Int       Date:  1996-06       Impact factor: 10.612

3.  7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure.

Authors:  P K Moore; R C Babbedge; P Wallace; Z A Gaffen; S L Hart
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

4.  Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake.

Authors:  H M Siragy; M M Ibrahim; A A Jaffa; R Mayfield; H S Margolius
Journal:  Hypertension       Date:  1994-06       Impact factor: 10.190

5.  Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat.

Authors:  D Macari; S Bottari; S Whitebread; M De Gasparo; N Levens
Journal:  Eur J Pharmacol       Date:  1993-11-02       Impact factor: 4.432

6.  Angiotensin II: endothelium-derived nitric oxide interaction in conscious rats.

Authors:  D H Sigmon; J M Newman; W H Beierwaltes
Journal:  J Am Soc Nephrol       Date:  1994-03       Impact factor: 10.121

7.  Stimulation of renal interstitial bradykinin by sodium depletion.

Authors:  H M Siragy; A A Jaffa; H S Margolius
Journal:  Am J Hypertens       Date:  1993-10       Impact factor: 2.689

8.  Angiotensin II receptor subtypes in cultured rat renal mesangial cells.

Authors:  P Ernsberger; J Zhou; T H Damon; J G Douglas
Journal:  Am J Physiol       Date:  1992-09

9.  Identification of imidazole as L-arginine-competitive inhibitor of porcine brain nitric oxide synthase.

Authors:  B Mayer; P Klatt; E R Werner; K Schmidt
Journal:  FEBS Lett       Date:  1994-08-22       Impact factor: 4.124

10.  Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney.

Authors:  M G Mohaupt; J L Elzie; K Y Ahn; W L Clapp; C S Wilcox; B C Kone
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

View more
  93 in total

1.  The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice.

Authors:  C D Searles; D G Harrison
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 2.  Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor.

Authors:  R M Carey; Z Q Wang; H M Siragy
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

3.  Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure.

Authors:  Aaron J Polichnowski; Limin Lu; Allen W Cowley
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

4.  Combined aliskiren and amlodipine reduce albuminuria via reduction in renal inflammation in diabetic rats.

Authors:  Luis C Matavelli; Jiqian Huang; Helmy M Siragy
Journal:  J Cardiovasc Pharmacol       Date:  2012-03       Impact factor: 3.105

Review 5.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

6.  Angiotensin II type 2 receptor-mediated inhibition of NaCl absorption is blunted in thick ascending limbs from Dahl salt-sensitive rats.

Authors:  Nancy J Hong; Jeffrey L Garvin
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

Review 7.  Angiotensin II type-2 receptor-specific effects on the cardiovascular system.

Authors:  Ying Li; Xiao-Hui Li; Hong Yuan
Journal:  Cardiovasc Diagn Ther       Date:  2012-03

Review 8.  The role of angiotensin II-stimulated renal tubular transport in hypertension.

Authors:  Kevin D Burns; Ningjun Li
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

Review 9.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

10.  Asymmetric dimethylarginine in angiotensin II-induced hypertension.

Authors:  Jennifer M Sasser; Natasha C Moningka; Mark W Cunningham; Byron Croker; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-16       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.